Asia is home to more than half of all humans, spread across populations with strikingly different genetic histories, and the conditions that cluster in these populations reflect that diversity. There is no single “Asian genetic disease” list. Instead, the landscape breaks into regional patterns: thalassemia and G6PD deficiency dominate tropical and subtropical zones from South to Southeast Asia, a unique alcohol-metabolism variant raises cancer risk across East Asia, South Asian populations carry elevated rates of certain heart and recessive diseases driven by centuries of endogamy, and East Asian children face the world’s highest rates of Kawasaki disease and moyamoya disease. Understanding these patterns matters not just for diagnosis but for drug safety, newborn screening, and the growing push to close a genomic data gap that leaves many Asian populations underserved by modern precision medicine.
Why Asian Populations Have Distinct Genetic Disease Patterns
The genetic diversity across Asia is enormous. South Asia alone is better understood not as one large population but as hundreds of small, historically isolated groups. A study assembling genome-wide data from over 2,800 individuals across more than 260 South Asian groups identified 81 distinct communities that descend from founder events more extreme than those seen in Ashkenazi Jewish or Finnish populations, both of which are well known for elevated rates of recessive disease.1PubMed Central. The promise of discovering population-specific disease-associated genes in South Asia A systematic review and meta-analysis of genetic differentiation across South Asian groups found moderate-to-high population structure overall, with the most extreme divergence observed between tribal and non-tribal groups, sometimes comparable to continental-level genetic differences.2PubMed Central. Human genetic diversity across South Asian populations: A systematic review and meta-analysis
What drives this? Endogamy, the practice of marrying within one’s community, has been the norm for many South Asian groups for hundreds or thousands of years. Combined with consanguinity (marriage between close relatives, particularly first cousins) in parts of South Asia, Pakistan, and the Middle East, these practices concentrate rare genetic variants within communities. Research on South Asian medical cohorts found that rates of rare homozygous variants can reach up to 100 times those seen in outbred populations.3Nature Communications. South Asian medical cohorts reveal strong founder effects and high rates of homozygosity In a study of Punjabi families with rare genetic diseases, consanguinity was present in roughly nine out of ten families, and most of those marriages were between first cousins.4Scientific Reports. Molecular Epidemiology and Variant Spectrum of Rare Genetic Diseases in the Punjabi Population: A Genomic Perspective from South Asia Meanwhile, East and Southeast Asian populations have their own distinct patterns shaped by different evolutionary pressures, including intense historical malaria exposure in tropical regions and unique bottleneck events during migration.
Thalassemia Across South, East, and Southeast Asia
Thalassemia is arguably the most widespread inherited blood disorder across Asia. It encompasses a family of conditions in which the body makes abnormal or insufficient hemoglobin, the oxygen-carrying protein in red blood cells. Both alpha-thalassemia and beta-thalassemia are common, but their prevalence and the specific mutations vary by region.
Southeast Asia has the most complex thalassemia picture anywhere on Earth. Alpha-thalassemia, beta-thalassemia, hemoglobin E, and hemoglobin Constant Spring all circulate at high frequencies, and these abnormal genes combine in over 60 different ways to produce a wide spectrum of disease severity.5PubMed Central. Haemoglobinopathies in southeast Asia Among the most serious forms are Hb Bart’s hydrops fetalis (a lethal condition caused by homozygous alpha-thalassemia-1), homozygous beta-thalassemia, and beta-thalassemia combined with hemoglobin E. That last pairing, HbE beta-thalassemia, is by far the most common severe form of beta-thalassemia in Asia and accounts for roughly half of all clinically severe beta-thalassemia cases worldwide.6PubMed Central. The hemoglobin E thalassemias
A systematic analysis of thalassemia burden across Asian regions from 1990 to 2021 found that Southeast Asia had the highest mortality and disability burden, while East Asia had the highest age-standardized prevalence. Among individual countries, Pakistan had the highest age-standardized mortality rate for thalassemia.7PubMed Central. Current status and trends in thalassemia burden across South, East and Southeast Asia, 1990–2021: a systematic analysis for the global burden of disease study 2021 The reason thalassemia persists at such high frequencies is evolutionary: carrying one copy of a thalassemia gene offers some protection against malaria, so in regions with heavy historical malaria exposure, these variants were selected for over generations.8PubMed Central. Human genetic variations conferring resistance to malaria
G6PD Deficiency and Its Overlap With Malaria Zones
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common enzyme deficiency in humans, and it follows a geographic pattern that closely mirrors historical malaria belts. The enzyme normally protects red blood cells from oxidative damage. When it is missing or deficient, exposure to certain foods (classically fava beans), infections, or medications can trigger a sudden breakdown of red blood cells.
Across Asia, prevalence in males ranges from roughly 3 to 4 percent, which is lower than in African populations but much higher than in Europeans.9PubMed. The ethnogeographic variability of genetic factors underlying G6PD deficiency The specific genetic variants behind the deficiency differ by region. In South Asia, the Mediterranean, Kerala, and Gond variants predominate. In East Asian populations, the Canton, Kaiping, and Viangchan variants are most common.9PubMed. The ethnogeographic variability of genetic factors underlying G6PD deficiency Even within a single country, the picture can shift: in Indonesia, the variant distribution differs between western and eastern populations, reflecting two distinct historical migration waves.10PubMed Central. Distribution of G6PD deficiency genotypes among Southeast Asian populations
This matters clinically because the severity of G6PD deficiency depends on the variant. Some cause chronic anemia, while others only become apparent when triggered by a specific drug or food. Anti-malarial drugs like primaquine are a particular concern in Southeast Asian populations, since prescribing them without screening for G6PD deficiency can cause life-threatening hemolytic crises in affected individuals.
The ALDH2 Variant and Alcohol-Related Cancer Risk
One of the most distinctive genetic features of East Asian populations is a single-point mutation in the ALDH2 gene, sometimes called the “Asian flush” gene. When you drink alcohol, your body first converts it to acetaldehyde (a toxic compound) and then breaks that down with the enzyme ALDH2. About 45 percent of Han Chinese carry a variant, ALDH2*2, that cripples this second step, causing acetaldehyde to accumulate.11PubMed Central. Novel and prevalent non-East Asian ALDH2 variants; Implications for global susceptibility to aldehydes’ toxicity The immediate result is the well-known facial flushing, nausea, and rapid heartbeat after even a small amount of alcohol. The long-term consequence is more serious.
Because acetaldehyde is a known carcinogen, people with the ALDH2*2 variant who drink alcohol face a disproportionately elevated risk of certain cancers. The strongest evidence is for esophageal cancer and cancers of the mouth and throat. A systematic review and meta-analysis found that the dose-response curves for liver, esophageal, and oral cavity cancers were steeper for carriers of the inactive ALDH2 variant, resulting in a higher burden of alcohol-related cancer than standard global estimates predict.12PubMed. ALDH2 polymorphism, alcohol intake and the attributable burden of cancer in East Asia: systematic review, meta-analysis, and modeling study East Asians may be more susceptible to the carcinogenic effects of alcohol partly because of this high allele frequency.13PubMed Central. ALDH2 polymorphism and alcohol-related cancers in Asians: a public health perspective The practical takeaway is straightforward: if you flush when you drink, that is not a harmless quirk. It is a signal that your body handles alcohol-derived toxins less efficiently, and even moderate drinking carries a greater cancer risk for you than for someone without the variant.
A South Asian Heart Disease Variant
South Asian populations have long been known to carry a higher burden of cardiovascular disease than most other groups, and part of that risk has a genetic component. A 25-base-pair deletion in the MYBPC3 gene, which encodes a structural protein in heart muscle, is found in roughly 4 percent of people of Indian subcontinental ancestry. An initial study linked this deletion to heritable cardiomyopathies and a substantially increased risk of heart failure.14Nature Genetics. A common MYBPC3 variant associated with cardiomyopathies in South Asia
More recent work has refined the picture. A reevaluation found that much of the heart-disease risk previously blamed on the 25-bp deletion alone could actually be explained by a subset of carriers who also carry a second, rarer variant on the same stretch of DNA. When researchers excluded people who carried both variants, the deletion by itself no longer showed a significant difference between heart-disease patients and controls.15PubMed Central. Reevaluation of the South Asian MYBPC3 Δ25bp Intronic Deletion in Hypertrophic Cardiomyopathy This is a good example of how founder variants common in one population can be misinterpreted when studied in isolation. Still, the combined haplotype carrying both changes remains a clinically important risk factor in South Asians, and genetic testing in this population can flag individuals who need closer cardiac monitoring.
Moyamoya Disease and Kawasaki Disease
Two vascular diseases show a striking concentration in East Asian populations that is only partly explained by genetics.
Moyamoya disease causes progressive narrowing of arteries at the base of the brain, which can lead to strokes even in children and young adults. It occurs worldwide, but its incidence in Japan, South Korea, and China dwarfs that of other regions. A genome-wide study identified the gene RNF213 as the first confirmed susceptibility gene for moyamoya disease. A single founder mutation in this gene, p.R4810K, was found in the vast majority of affected Japanese families and showed a remarkably strong disease association in both Japanese and Korean populations.16Journal of Human Genetics. A genome-wide association study identifies RNF213 as the first Moyamoya disease gene The same variant carried a weaker but still significant association in Chinese populations.17PubMed. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations The variant is present in roughly 1-2 percent of the general East Asian population, but only a small fraction of carriers develop the disease, so additional triggers, possibly infectious or environmental, are thought to play a role.
Kawasaki disease is a childhood vasculitis that inflames blood vessels throughout the body, with its most dangerous complication being coronary artery damage. It is the leading cause of acquired heart disease in children in developed nations. Incidence is highest in Northeast Asia, where close to 1 in 100 Japanese children develop the condition by age five.18PubMed Central. Kawasaki Disease: Global Burden and Genetic Background A large genome-wide study across multiple Asian cohorts identified a variant in the immune receptor gene FCGR2A as a significant risk factor, consistent with the idea that the disease involves an exaggerated immune response in genetically predisposed children.19Nature Genetics. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease Children of East Asian ancestry living in Western countries still have higher rates than their non-Asian peers, underscoring the genetic contribution even when the environmental setting changes.
Drug Reactions Linked to HLA Genes
Some of the most immediately actionable genetic differences in Asian populations involve drug safety. Certain immune-system genes called HLA variants, which differ in frequency across ancestries, can trigger life-threatening skin reactions to common medications.
Carbamazepine, widely used for epilepsy and nerve pain, is strongly associated with Stevens-Johnson syndrome and toxic epidermal necrolysis (severe blistering reactions that can be fatal) in carriers of the HLA-B*1502 allele. This allele is rare in Europeans but common in many Southeast and East Asian populations. In a Thai study, about 88 percent of patients who developed these severe reactions to carbamazepine carried HLA-B*1502, compared to roughly 12 percent of those who tolerated the drug.20PubMed. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population A systematic review and meta-analysis confirmed that the association is strong and particularly relevant for Asian patients, and recommended genetic testing before prescribing carbamazepine in these populations.21JAMA Dermatology. Relationship Between the HLA-B*1502 Allele and Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Systematic Review and Meta-analysis Taiwan was one of the first places to implement universal pre-prescription screening for this allele, a policy that dramatically reduced the incidence of these reactions.22PubMed. Carbamazepine-induced toxic effects and HLA-B*1502 screening in Taiwan
A parallel story involves allopurinol, used to treat gout, and the HLA-B*58:01 allele. A living systematic review found that this allele is carried by roughly 13 percent of South and Southeast Asians and about 6 percent of East and Central Asians, compared to around 2 percent of Europeans. The allele was associated with more than a hundredfold increase in the odds of severe skin reactions to allopurinol.23PubMed Central. HLA-B*58:01 genotyping prevalence and the association with allopurinol-induced severe cutaneous adverse reactions: a living systematic review and meta-analysis Screening before prescribing allopurinol is increasingly recommended in populations with high allele frequencies.
Citrin Deficiency and Wilson Disease
Two inherited metabolic conditions are particularly concentrated in East Asian populations, and both illustrate how the same disease can have different genetic roots in different countries.
Citrin deficiency is caused by mutations in the SLC25A13 gene and disrupts the body’s handling of certain amino acids and the urea cycle. In infants, it can cause a liver condition called neonatal intrahepatic cholestasis; in adults, it can lead to severe metabolic crises if protein intake is insufficient. It is highly prevalent in East Asian countries.24PubMed Central. Clinical landscape of citrin deficiency: A global perspective on a multifaceted condition In China, the most common causative mutation varies between northern and southern regions, with higher allelic diversity in the north.25PubMed Central. Molecular diagnosis of pediatric patients with citrin deficiency in China: SLC25A13 mutation spectrum and the geographic distribution In Korea, a different mutation tops the list.26PubMed Central. Carrier Frequency and Prevalence of Citrin Deficiency in East Asians and Koreans Based on Comprehensive Analysis of Pathogenic SLC25A13 Variants This kind of intra-regional variation matters for newborn screening programs, which need to test for the mutations actually circulating in a given population.
Wilson disease, caused by mutations in the ATP7B gene, leads to dangerous copper accumulation in the liver and brain. While it occurs worldwide, the Chinese population has a unique, high-frequency mutation profile centered on two specific changes, R778L and P992L.27Frontiers in Molecular Biosciences. Recent advances in research on high-frequency mutations in the ATP7B gene associated with Wilson disease in the Chinese population: from genetic evolution to precision medicine The mutation spectrum in Vietnamese patients is fairly different from other East Asian populations, meaning that diagnostic panels designed for Chinese or Japanese patients may miss cases in Vietnam.28PubMed Central. Mutation spectrum of ATP7B gene in pediatric patients with Wilson disease in Vietnam This population-specific variation is a recurring theme: a genetic test that works well in one Asian country may not be adequate in another.
Myopia and Genetic Susceptibility in East Asia
The myopia epidemic in East Asia is dramatic enough that it can seem purely environmental, driven by intense studying and limited outdoor time. But genetics plays a substantial role. Myopia is more prevalent and severe among East Asians than among people of European descent, with individuals of Chinese, Japanese, and Korean ancestry particularly affected.29PubMed Central. Myopia Genetics and Heredity Both genetic and environmental factors contribute to the gap.30PubMed. Myopia Genetics-The Asia-Pacific Perspective
A genome-wide association study in Asian populations identified nine loci linked to high myopia, six of which were novel. The pathway analysis pointed to nervous system processes, including synaptic signaling and neuronal development, as playing a role in how high myopia develops.31PubMed. Genome-Wide Association Study in Asians Identifies Novel Loci for High Myopia and Highlights a Nervous System Role in Its Pathogenesis This does not mean that environmental factors are unimportant. They clearly are. But the genetic predisposition helps explain why the same lifestyle changes (more near-work, less outdoor time) have produced a more severe myopia wave in East Asia than in other regions with similar educational pressures.
Spinocerebellar Ataxias Across Asian Countries
The spinocerebellar ataxias (SCAs) are a group of inherited neurological disorders that cause progressive loss of coordination. They are individually rare but collectively significant, and their subtype distribution varies wildly across Asia. Overall, the most common subtypes include SCA1, SCA2, SCA3, and SCA6, but the relative prevalence shifts from country to country, and some subtypes are essentially confined to specific Asian populations.32PubMed. Spinocerebellar ataxias in Asia: Prevalence, phenotypes and management
In Malaysia, for example, SCA3 (also known as Machado-Joseph disease) accounts for about 69 percent of genetically confirmed cases, followed by SCA2 and SCA1.33PubMed Central. Frequency of Spinocerebellar Ataxia type 1, 2, 3,6 and 7 and clinical profile of Spinocerebellar Ataxia type 3 in Malaysia In South Korea, researchers recently found that SCA36, a subtype not routinely tested for, was present in about 12 percent of previously undiagnosed ataxia families, suggesting it may be more common than previously recognized in that population.34European Journal of Human Genetics. Another common genetic ataxia in South Korea: Spinocerebellar ataxia 36 Some subtypes, including SCA12 and SCA31, appear to be rather specific to certain Asian populations. For families seeking a genetic diagnosis, knowing which subtypes to test for depends heavily on their specific ethnic and geographic background.
Hereditary Cancer Variants in Asian Populations
Hereditary breast and ovarian cancer linked to BRCA1 and BRCA2 mutations occurs in every population, but the specific mutations differ. In Japan, a founder mutation called BRCA1 L63X was identified in a notable proportion of carriers through the Japanese hereditary breast and ovarian cancer consortium. This single mutation accounted for 26 out of 88 identified BRCA1 carriers, and cancers in patients with this founder mutation showed distinct clinical characteristics compared to patients with other BRCA1 or BRCA2 changes.35PubMed Central. Analysis of clinical characteristics of breast cancer patients with the Japanese founder mutation BRCA1 L63X Similar population-specific founder mutations have been identified across other Asian groups, reinforcing the point that a genetic test designed to catch European founder mutations (like the well-known Ashkenazi Jewish BRCA variants) may miss the variants that matter most in Asian patients.
The Genomic Data Gap Affecting Asian Patients
Perhaps the most important cross-cutting issue in Asian genetic disease is not a specific condition but a systemic problem: the majority of the world’s genomic data comes from people of European descent. This creates real consequences for patients of Asian ancestry. When a genetic test finds an unfamiliar variant in someone whose population is underrepresented in databases, that variant is far more likely to be classified as a “variant of uncertain significance,” a frustrating result that gives neither a clear diagnosis nor a clear all-clear. Asian patients have a higher rate of receiving these ambiguous results after cancer gene panel testing.36PubMed. Cancer patients’ experience of receiving variant of uncertain significance results: An Asian perspective
A study comparing data available for putative breast cancer risk variants found that populations of South Asian ancestry had the largest knowledge gap: over 43 percent of their population-specific variants were not reported in the major clinical variant database ClinVar, compared to 20 to 30 percent for other non-European groups.37PubMed Central. Putative breast cancer risk variants from populations of South Asian ancestry are under-represented in public variant classification databases Researchers studying clinically relevant variants in ancestrally diverse Asian genomes have noted that this “informational disparity” makes clinical interpretation harder for non-Europeans, and that Asian-specific pathogenic variants currently mislabeled as uncertain could be reclassified with more widespread testing.38Nature Communications. Analysis of clinically relevant variants from ancestrally diverse Asian genomes
Large-scale efforts are underway to close this gap. The GenomeAsia 100K Project has produced a whole-genome sequencing reference dataset from over 1,700 individuals across 219 population groups and 64 Asian countries, cataloguing genetic variation, population structure, and disease associations.39PubMed Central. The GenomeAsia 100K Project enables genetic discoveries across Asia A separate East Asian reference panel of over 14,000 whole genomes has improved the ability to detect rare and low-frequency variants, and genome-wide association studies using this panel identified 39 previously unknown genetic associations, more than half of which were specific to East Asian populations.40PubMed Central. A whole-genome reference panel of 14,393 individuals for East Asian populations accelerates discovery of rare functional variants As these datasets grow, the expectation is that diagnostic testing, drug safety screening, and risk assessment will become more accurate for the billions of people whose genetic backgrounds have historically been underrepresented in medical research.
Endogamy, Consanguinity, and Hidden Recessive Disease
The founder effects and endogamy described earlier have a direct medical consequence that often goes unrecognized outside of genetics clinics: a higher burden of autosomal recessive diseases in many South Asian communities. Whole-exome sequencing of individuals from four highly endogamous South Indian populations revealed an inbreeding rate of 59 percent and uncovered over 1,200 previously unreported exonic variants, including 23 predicted to be harmful when present in two copies, a scenario that becomes increasingly likely in communities where everyone shares recent common ancestors.41PubMed. Endogamy and high prevalence of deleterious mutations in India: evidence from strong founder events
The most extreme levels of estimated consanguinity have been observed in isolated groups from mainland India, the Andaman Islands, and parts of Pakistan, though highly endogamous communities exist across South and Southeast Asia.42Scientific Reports. Inbreeding and deleterious variation in South Asian populations For these communities, the clinical implication is that conditions rarely seen elsewhere may cluster in families. The flip side is an opportunity: these concentrated founder variants make South Asia a uniquely powerful setting for discovering new disease genes, since the same rare variants that cause illness also appear at high enough frequencies to be statistically detectable in relatively small study groups.